top of page

Reformulating to improve bioavailability

Current drug candidates : OXL001and OXL002

  • Based on an off patent drug previously approved for a different indication

  • Undergoing formulation development to enhance performance and reduce production costs


  • Further formulation development underway to reduce pill burden and improve patient compliance, thus improving the patient experience

  • Both will provide substantial Intellectual Property opportunities through novel formulation development

Doctor High Five
Friendly Young Doctor
Female Assistance
bottom of page